Among them, the echinoderm microtubule-associated protein-like 4 (EML4)–ALK fusion was recognized in 2007 as a representative oncogenic driver fusion in approximately 3–7% of NSCLC [90]. Here, EML4 is linked to non-small cell lung carcinoma.